Progenics Pharmaceuticals (PGNX)
Create an AlertProgenics Pharmaceuticals Valuation Percentage
Progenics Pharmaceuticals Valuation Percentage Chart
View Valuation Percentage for PGNX.
Start Your YCharts Pro Gold Membership.
Progenics Pharmaceuticals Historical Valuation Percentage Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 19, 2013 | Go Pro |
| March 31, 2013 | Go Pro |
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| June 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
| June 30, 2009 | Go Pro |
| March 31, 2009 | Go Pro |
| Dec. 31, 2008 | Go Pro |
| Sept. 30, 2008 | Go Pro |
| June 30, 2008 | Go Pro |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
Learn More
View Valuation Percentage for PGNX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
PGNX Valuation Percentage Benchmarks
| Companies | |
|---|---|
| Santarus | Go Pro |
| Salix Pharmaceuticals | Go Pro |
| Jazz Pharmaceuticals | Go Pro |
PGNX Valuation Percentage Rankings
| Overall |
78th percentile 3643 of 16782 |
| Sector |
75th percentile 341 of 1410 in Healthcare |
| Industry |
84th percentile 70 of 454 in Biotechnology |
PGNX Valuation Percentage Range, Past 5 Years
| Minimum | Go Pro | Jun 2012 |
| Maximum | Go Pro | Mar 2012 |
| Average | Go Pro |
PGNX News
Street Insider Jun 11
